AMANTADINE

AMANTADINE was reported 13067 times

These side effects are most commonly reported by patients taking AMANTADINE:

# Side effect Count
0 FALL 1821
1 HALLUCINATION 1356
2 DRUG INEFFECTIVE 1295
3 FATIGUE 1118
4 DYSKINESIA 1114
5 DIZZINESS 962
6 GAIT DISTURBANCE 922
7 DEATH 898
8 TREMOR 819
9 NAUSEA 694
10 PARKINSON^S DISEASE 678
11 ASTHENIA 663
12 CONDITION AGGRAVATED 658
13 CONFUSIONAL STATE 650
14 BALANCE DISORDER 639
15 SOMNOLENCE 637
16 URINARY TRACT INFECTION 632
17 INSOMNIA 579
18 CONSTIPATION 570
19 OFF LABEL USE 546
20 HEADACHE 493
21 PRODUCT DOSE OMISSION ISSUE 471
22 HALLUCINATION, VISUAL 461
23 PAIN 459
24 MALAISE 455
25 ANXIETY 454
26 DEPRESSION 444
27 WEIGHT DECREASED 411
28 FEELING ABNORMAL 397
29 COUGH 387
30 DYSPNOEA 381
31 MULTIPLE SCLEROSIS RELAPSE 381
32 MEMORY IMPAIRMENT 372
33 PERIPHERAL SWELLING 364
34 MOBILITY DECREASED 360
35 MUSCULAR WEAKNESS 344
36 ON AND OFF PHENOMENON 343
37 PNEUMONIA 343
38 DRY MOUTH 335
39 VOMITING 308
40 DRUG INTERACTION 300
41 DYSPHAGIA 299
42 MUSCULOSKELETAL STIFFNESS 297
43 PAIN IN EXTREMITY 289
44 FREEZING PHENOMENON 286
45 SPEECH DISORDER 285
46 BACK PAIN 279
47 SEIZURE 278
48 MUSCLE SPASMS 274
49 DIARRHOEA 269
50 HYPOTENSION 269
51 HYPOAESTHESIA 260
52 DEVICE ISSUE 253
53 AGITATION 242
54 DECREASED APPETITE 240
55 HYPERTENSION 239
56 DYSTONIA 229
57 PYREXIA 227
58 DEHYDRATION 221
59 LOSS OF CONSCIOUSNESS 221
60 MULTIPLE SCLEROSIS 219
61 SLEEP DISORDER 217
62 ARTHRALGIA 209
63 GENERAL PHYSICAL HEALTH DETERIORATION 205
64 PARAESTHESIA 204
65 COVID-19 203
66 HYPERHIDROSIS 202
67 VISION BLURRED 201
68 THERAPEUTIC RESPONSE SHORTENED 197
69 VISUAL IMPAIRMENT 195
70 CONTUSION 192
71 PSYCHOTIC DISORDER 192
72 PRURITUS 191
73 COGNITIVE DISORDER 190
74 MUSCLE RIGIDITY 188
75 OEDEMA PERIPHERAL 188
76 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 188
77 RASH 186
78 DELUSION 184
79 HOSPITALISATION 174
80 GAIT INABILITY 172
81 TOXICITY TO VARIOUS AGENTS 171
82 WEIGHT INCREASED 170
83 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 168
84 THERAPY CESSATION 168
85 AGGRESSION 166
86 DELIRIUM 165
87 UNEVALUABLE EVENT 161
88 PRODUCT DOSE OMISSION 160
89 PRODUCT USE IN UNAPPROVED INDICATION 158
90 ABNORMAL DREAMS 153
91 BLOOD PRESSURE INCREASED 151
92 DEPRESSED MOOD 151
93 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 149
94 DEVICE DISLOCATION 148
95 MOVEMENT DISORDER 147
96 DYSARTHRIA 146
97 HEAD INJURY 145
98 NASOPHARYNGITIS 142
99 ACUTE KIDNEY INJURY 141
100 ADVERSE DRUG REACTION 139
101 DYSSTASIA 139
102 NEUROLEPTIC MALIGNANT SYNDROME 138
103 BRADYKINESIA 136
104 DISORIENTATION 136
105 NIGHTMARE 135
106 PRODUCT USE ISSUE 135
107 ALOPECIA 134
108 HYPERSOMNIA 133
109 ABDOMINAL DISCOMFORT 131
110 INFECTION 129
111 DRUG DOSE OMISSION 128
112 FLUSHING 126
113 STRESS 126
114 ABDOMINAL PAIN UPPER 124
115 ORTHOSTATIC HYPOTENSION 124
116 DEMENTIA 123
117 SEROTONIN SYNDROME 123
118 SYNCOPE 122
119 DEVICE OCCLUSION 120
120 DISTURBANCE IN ATTENTION 119
121 SEPSIS 119
122 ABNORMAL BEHAVIOUR 117
123 CEREBROVASCULAR ACCIDENT 117
124 HIP FRACTURE 117
125 LETHARGY 117
126 ERYTHEMA 115
127 INCORRECT DOSE ADMINISTERED 115
128 ABDOMINAL PAIN 112
129 AMNESIA 112
130 CHEST PAIN 112
131 OVERDOSE 112
132 DRUG HYPERSENSITIVITY 110
133 DYSPHONIA 108
134 PNEUMONIA ASPIRATION 108
135 MENTAL STATUS CHANGES 106
136 STOMA SITE DISCHARGE 106
137 UNDERDOSE 106
138 BLOOD PRESSURE DECREASED 105
139 CHOKING 105
140 TACHYCARDIA 104
141 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 104
142 URINARY INCONTINENCE 103
143 ADVERSE EVENT 100
144 SUICIDAL IDEATION 99
145 INFLUENZA 98
146 PARANOIA 97
147 THERAPEUTIC RESPONSE UNEXPECTED 96
148 APHASIA 95
149 URINARY RETENTION 95
150 RESTLESSNESS 94
151 HYPOPHAGIA 93
152 RENAL FAILURE 92
153 MUSCLE SPASTICITY 91
154 HEART RATE INCREASED 90
155 HYPERSENSITIVITY 89
156 MIGRAINE 87
157 DRUG INTOLERANCE 86
158 JOINT SWELLING 86
159 DISEASE PROGRESSION 85
160 STOMA SITE ERYTHEMA 84
161 HYPOKINESIA 83
162 MIDDLE INSOMNIA 83
163 DRUG WITHDRAWAL SYNDROME 82
164 HYPERKINESIA 82
165 MYALGIA 82
166 PARKINSON^S DISEASE PSYCHOSIS 82
167 TREATMENT NONCOMPLIANCE 82
168 RIB FRACTURE 81
169 ANAEMIA 80
170 NERVOUSNESS 80
171 SWELLING 80
172 CHILLS 79
173 DEVICE USE ISSUE 78
174 DIPLOPIA 78
175 PRESCRIBED UNDERDOSE 78
176 RENAL IMPAIRMENT 78
177 WITHDRAWAL SYNDROME 78
178 ATRIAL FIBRILLATION 77
179 DIZZINESS POSTURAL 77
180 PALPITATIONS 77
181 PARKINSONISM 77
182 ABDOMINAL DISTENSION 76
183 CARDIAC ARREST 76
184 DEVICE BREAKAGE 76
185 MYOCLONUS 76
186 NEPHROLITHIASIS 76
187 POOR QUALITY SLEEP 76
188 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 75
189 FEELING HOT 75
190 INJECTION SITE PAIN 75
191 SEDATION 75
192 GENERALISED TONIC-CLONIC SEIZURE 74
193 HALLUCINATIONS, MIXED 74
194 INFLUENZA LIKE ILLNESS 74
195 NEUROPATHY PERIPHERAL 74
196 POLLAKIURIA 74
197 RESPIRATORY FAILURE 74
198 SINUSITIS 74
199 UNRESPONSIVE TO STIMULI 74
200 ENCEPHALOPATHY 73
201 HALLUCINATION, AUDITORY 73
202 ILL-DEFINED DISORDER 73
203 DYSPEPSIA 72
204 HOSPICE CARE 72
205 HOT FLUSH 72
206 CATARACT 71
207 CELLULITIS 71
208 DEVICE LEAKAGE 71
209 GASTROINTESTINAL DISORDER 71
210 INTENTIONAL PRODUCT MISUSE 71
211 MOTOR DYSFUNCTION 71
212 CYSTITIS 70
213 THERAPY NON-RESPONDER 70
214 DEVICE DIFFICULT TO USE 69
215 VERTIGO 69
216 CHEST DISCOMFORT 68
217 LIMB DISCOMFORT 68
218 NECK PAIN 68
219 OROPHARYNGEAL PAIN 68
220 THERAPEUTIC PRODUCT EFFECT DECREASED 68
221 IRRITABILITY 67
222 THERAPEUTIC PRODUCT EFFECT VARIABLE 67
223 COMPLETED SUICIDE 66
224 IMPULSE-CONTROL DISORDER 66
225 MYOCARDIAL INFARCTION 66
226 PULMONARY EMBOLISM 66
227 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 65
228 TARDIVE DYSKINESIA 65
229 URTICARIA 65
230 HYPONATRAEMIA 63
231 MUSCLE TIGHTNESS 63
232 RHABDOMYOLYSIS 63
233 INJECTION SITE ERYTHEMA 62
234 PRODUCT RESIDUE PRESENT 62
235 BLOOD PRESSURE FLUCTUATION 61
236 BRADYCARDIA 61
237 BURNING SENSATION 61
238 DEEP BRAIN STIMULATION 61
239 SENSORY DISTURBANCE 61
240 SKIN DISCOLOURATION 61
241 THERAPY INTERRUPTED 61
242 WHITE BLOOD CELL COUNT DECREASED 61
243 PRESCRIBED OVERDOSE 60
244 PSYCHOMOTOR HYPERACTIVITY 60
245 CONVULSION 59
246 ILLNESS 59
247 INTENTIONAL PRODUCT USE ISSUE 59
248 STOMA SITE INFECTION 59
249 STOMA SITE PAIN 59
250 BRONCHITIS 58
251 INTENTIONAL UNDERDOSE 58
252 NONSPECIFIC REACTION 58
253 SURGERY 57
254 MENTAL DISORDER 56
255 NEUROTOXICITY 56
256 PANIC ATTACK 56
257 CARDIAC DISORDER 55
258 FEEDING DISORDER 55
259 DROOLING 54
260 THROAT IRRITATION 54
261 CARDIAC FAILURE 53
262 MUSCLE TWITCHING 53
263 NOCTURIA 53
264 PERONEAL NERVE PALSY 53
265 LYMPHOCYTE COUNT DECREASED 52
266 NEURALGIA 52
267 REHABILITATION THERAPY 52
268 SKIN LACERATION 52
269 EYE PAIN 51
270 LIVEDO RETICULARIS 51
271 MICTURITION URGENCY 51
272 ASTHMA 50
273 DRY EYE 50
274 DYSURIA 50
275 INJECTION SITE BRUISING 50
276 INJECTION SITE REACTION 50
277 RESTLESS LEGS SYNDROME 50
278 RHINORRHOEA 50
279 DISCOMFORT 49
280 DRUG EFFECT DECREASED 49
281 GASTROOESOPHAGEAL REFLUX DISEASE 49
282 MUSCULOSKELETAL DISORDER 49
283 ARTHRITIS 48
284 BLOOD CREATININE INCREASED 48
285 CEREBRAL HAEMORRHAGE 48
286 DRUG EFFECT INCOMPLETE 48
287 DOPAMINE DYSREGULATION SYNDROME 47
288 INTESTINAL OBSTRUCTION 47
289 CHRONIC KIDNEY DISEASE 46
290 MENTAL IMPAIRMENT 46
291 THROMBOSIS 46
292 WHITE BLOOD CELL COUNT INCREASED 46
293 ATAXIA 45
294 COORDINATION ABNORMAL 45
295 FEELING COLD 45
296 HAEMOGLOBIN DECREASED 45
297 DEPRESSED LEVEL OF CONSCIOUSNESS 44
298 HEPATIC ENZYME INCREASED 44
299 INTENTIONAL OVERDOSE 44
300 LEUKOCYTOSIS 44
301 LIMB INJURY 44
302 MOOD ALTERED 44
303 TRANSIENT ISCHAEMIC ATTACK 44
304 AKINESIA 43
305 ASPIRATION 43
306 CRYING 43
307 INCONTINENCE 43
308 OSTEOARTHRITIS 43
309 PARKINSONISM HYPERPYREXIA SYNDROME 43
310 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 43
311 ABASIA 42
312 BLADDER DISORDER 42
313 HEART RATE DECREASED 42
314 POSTURE ABNORMAL 42
315 STAPHYLOCOCCAL INFECTION 42
316 UPPER RESPIRATORY TRACT INFECTION 42
317 YAWNING 42
318 DECUBITUS ULCER 41
319 FLATULENCE 41
320 HAEMORRHAGE 41
321 HEMIPARESIS 41
322 HERPES ZOSTER 41
323 MANIA 41
324 NASAL CONGESTION 41
325 NO ADVERSE EVENT 41
326 UROSEPSIS 41
327 CORNEAL OEDEMA 40
328 EMOTIONAL DISTRESS 40
329 FLUID RETENTION 40
330 HYPERSEXUALITY 40
331 INJURY 40
332 JOINT INJURY 40
333 WALKING AID USER 40
334 ARRHYTHMIA 39
335 BLOOD PRESSURE ABNORMAL 39
336 COMA 39
337 PRODUCTIVE COUGH 39
338 RASH MACULAR 39
339 SWELLING FACE 39
340 BLINDNESS 38
341 DEEP VEIN THROMBOSIS 38
342 EXTRA DOSE ADMINISTERED 38
343 FEELING JITTERY 38
344 LYMPHOPENIA 38
345 SLEEP TALKING 38
346 SPUTUM DISCOLOURED 38
347 SUBDURAL HAEMATOMA 38
348 THINKING ABNORMAL 38
349 THROMBOCYTOPENIA 38
350 UPPER LIMB FRACTURE 38
351 BLOOD CREATINE PHOSPHOKINASE INCREASED 37
352 CENTRAL NERVOUS SYSTEM LESION 37
353 DIABETES MELLITUS 37
354 INITIAL INSOMNIA 37
355 INTERVERTEBRAL DISC PROTRUSION 37
356 PRESYNCOPE 37
357 SUICIDE ATTEMPT 37
358 ACUTE PSYCHOSIS 36
359 DRUG ABUSE 36
360 FEMUR FRACTURE 36
361 OEDEMA 36
362 PRODUCT DOSE OMISSION IN ERROR 36
363 SALIVARY HYPERSECRETION 36
364 THERAPEUTIC RESPONSE DECREASED 36
365 ANAL INCONTINENCE 35
366 BLOOD GLUCOSE INCREASED 35
367 CARDIAC FAILURE CONGESTIVE 35
368 HYPERTHERMIA 35
369 OXYGEN SATURATION DECREASED 35
370 RASH PRURITIC 35
371 RESPIRATORY DISTRESS 35
372 WHEELCHAIR USER 35
373 ACUTE RESPIRATORY FAILURE 34
374 BREAST CANCER 34
375 CHOLELITHIASIS 34
376 OBSESSIVE-COMPULSIVE DISORDER 34
377 REDUCED FACIAL EXPRESSION 34
378 STOMA SITE HAEMORRHAGE 34
379 BLOOD CHOLESTEROL INCREASED 33
380 INFUSION SITE ERYTHEMA 33
381 LOWER RESPIRATORY TRACT INFECTION 33
382 MALNUTRITION 33
383 PRE-EXISTING CONDITION IMPROVED 33
384 ANGER 32
385 AUTONOMIC NERVOUS SYSTEM IMBALANCE 32
386 CARDIO-RESPIRATORY ARREST 32
387 DEVICE USE ERROR 32
388 DRY SKIN 32
389 EXTRAPYRAMIDAL DISORDER 32
390 HYPOGLYCAEMIA 32
391 INCOHERENT 32
392 MUSCULOSKELETAL PAIN 32
393 PRODUCT QUALITY ISSUE 32
394 RENAL DISORDER 32
395 BEDRIDDEN 31
396 BLOOD POTASSIUM DECREASED 31
397 C-REACTIVE PROTEIN INCREASED 31
398 DEVICE KINK 31
399 EPILEPSY 31
400 ALTERED STATE OF CONSCIOUSNESS 30
401 ARTHROPATHY 30
402 CATATONIA 30
403 DYSGRAPHIA 30
404 ILLUSION 30
405 LEUKOPENIA 30
406 MULTIPLE ORGAN DYSFUNCTION SYNDROME 30
407 NEUTROPENIA 30
408 TINNITUS 30
409 BLISTER 29
410 CHROMATURIA 29
411 COMPULSIVE SHOPPING 29
412 CONTRAINDICATED PRODUCT ADMINISTERED 29
413 DRUG EFFECT LESS THAN EXPECTED 29
414 DYSKINESIA HYPERPYREXIA SYNDROME 29
415 EMOTIONAL DISORDER 29
416 FEAR 29
417 GASTROINTESTINAL HAEMORRHAGE 29
418 INFLAMMATION 29
419 INJECTION SITE PRURITUS 29
420 PALLOR 29
421 SKIN DISORDER 29
422 BODY TEMPERATURE INCREASED 28
423 DECREASED INTEREST 28
424 DYSGEUSIA 28
425 EPISTAXIS 28
426 HEAD DISCOMFORT 28
427 HYPOACUSIS 28
428 HYPOXIA 28
429 LOCALISED INFECTION 28
430 MATERNAL EXPOSURE DURING PREGNANCY 28
431 NERVE COMPRESSION 28
432 NIGHT SWEATS 28
433 ROAD TRAFFIC ACCIDENT 28
434 SPINAL OPERATION 28
435 STOMA SITE HYPERGRANULATION 28
436 TEMPERATURE INTOLERANCE 28
437 TREATMENT FAILURE 28
438 WOUND 28
439 BEHAVIOUR DISORDER 27
440 BLOOD URINE PRESENT 27
441 CEREBRAL ATROPHY 27
442 DEVICE ALARM ISSUE 27
443 DYSPHEMIA 27
444 ELECTROCARDIOGRAM QT PROLONGED 27
445 EXPIRED PRODUCT ADMINISTERED 27
446 GLAUCOMA 27
447 HAEMATOMA 27
448 HIP ARTHROPLASTY 27
449 LUNG DISORDER 27
450 NERVOUS SYSTEM DISORDER 27
451 PSYCHOTIC SYMPTOM 27
452 RESPIRATORY ARREST 27
453 SENSORY LOSS 27
454 SEPTIC SHOCK 27
455 SLUGGISHNESS 27
456 SPINAL FRACTURE 27
457 VIRAL INFECTION 27
458 ALANINE AMINOTRANSFERASE INCREASED 26
459 FINE MOTOR SKILL DYSFUNCTION 26
460 GENERAL SYMPTOM 26
461 HEART RATE IRREGULAR 26
462 IMPULSIVE BEHAVIOUR 26
463 INFUSION SITE PAIN 26
464 INJECTION SITE MASS 26
465 PULMONARY OEDEMA 26
466 SKIN EXFOLIATION 26
467 EYE DISORDER 25
468 HAEMATOCRIT DECREASED 25
469 HYPERNATRAEMIA 25
470 INTENTIONAL DOSE OMISSION 25
471 KIDNEY INFECTION 25
472 PRODUCT PHYSICAL ISSUE 25
473 RAPID EYE MOVEMENT SLEEP BEHAVIOUR DISORDER 25
474 STOMA COMPLICATION 25
475 ACCIDENTAL OVERDOSE 24
476 BLOOD SODIUM DECREASED 24
477 EYE SWELLING 24
478 FAECALOMA 24
479 GASTRITIS 24
480 GASTROENTERITIS VIRAL 24
481 HYPOKALAEMIA 24
482 HYPOTHYROIDISM 24
483 IMMOBILE 24
484 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 24
485 OPTIC NEURITIS 24
486 PHOTOPHOBIA 24
487 PLATELET COUNT DECREASED 24
488 SOMNAMBULISM 24
489 STOMA SITE REACTION 24
490 WRIST FRACTURE 24
491 DEVICE PHYSICAL PROPERTY ISSUE 23
492 DYSPNOEA EXERTIONAL 23
493 FOOT DEFORMITY 23
494 FOOT FRACTURE 23
495 FUNGAL INFECTION 23
496 LOWER LIMB FRACTURE 23
497 MOOD SWINGS 23
498 OSTEOMYELITIS 23
499 POLYNEUROPATHY 23
500 PRODUCT DISPENSING ERROR 23
501 PRODUCT PRESCRIBING ISSUE 23
502 PRODUCT SUBSTITUTION ISSUE 23
503 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 23
504 ACUTE MYOCARDIAL INFARCTION 22
505 AKATHISIA 22
506 COLD SWEAT 22
507 EMBEDDED DEVICE 22
508 EYE IRRITATION 22
509 EYE MOVEMENT DISORDER 22
510 GAMBLING DISORDER 22
511 INCORRECT DOSE ADMINISTERED BY DEVICE 22
512 INFUSION SITE NODULE 22
513 INJECTION SITE SWELLING 22
514 KNEE ARTHROPLASTY 22
515 PERSECUTORY DELUSION 22
516 PULMONARY THROMBOSIS 22
517 RENAL FAILURE ACUTE 22
518 SCREAMING 22
519 SLEEP APNOEA SYNDROME 22
520 SMALL INTESTINAL OBSTRUCTION 22
521 TACHYPNOEA 22
522 VISUAL ACUITY REDUCED 22
523 ACTIVITIES OF DAILY LIVING IMPAIRED 21
524 BLOOD GLUCOSE DECREASED 21
525 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 21
526 COMPLICATION ASSOCIATED WITH DEVICE 21
527 EATING DISORDER 21
528 FRUSTRATION TOLERANCE DECREASED 21
529 HYPERTONIA 21
530 HYPOCALCAEMIA 21
531 INFUSION RELATED REACTION 21
532 JOINT DISLOCATION 21
533 POST PROCEDURAL COMPLICATION 21
534 SCIATICA 21
535 SKIN ABRASION 21
536 ACUTE RESPIRATORY DISTRESS SYNDROME 20
537 ANKLE FRACTURE 20
538 APATHY 20
539 BRAIN FOG 20
540 DEVICE CONNECTION ISSUE 20
541 DEVICE MALFUNCTION 20
542 INJECTION SITE HAEMORRHAGE 20
543 JOINT STIFFNESS 20
544 LIBIDO DECREASED 20
545 LIP SWELLING 20
546 METABOLIC ACIDOSIS 20
547 NEUROGENIC BLADDER 20
548 NEUTROPHIL COUNT INCREASED 20
549 PARALYSIS 20
550 PELVIC FRACTURE 20
551 PLEURAL EFFUSION 20
552 PRODUCT ADMINISTRATION ERROR 20
553 PULMONARY HYPERTENSION 20
554 SINUS TACHYCARDIA 20
555 TENSION 20
556 THERAPY PARTIAL RESPONDER 20
557 THIRST 20
558 VENTRICULAR EXTRASYSTOLES 20
559 VITAMIN D DEFICIENCY 20
560 ANOSMIA 19
561 COLITIS 19
562 CONCUSSION 19
563 DEVICE DELIVERY SYSTEM ISSUE 19
564 DISEASE RECURRENCE 19
565 DRY THROAT 19
566 ERECTILE DYSFUNCTION 19
567 EUPHORIC MOOD 19
568 FORMICATION 19
569 GAZE PALSY 19
570 HERNIA 19
571 HYPERGLYCAEMIA 19
572 IMPAIRED HEALING 19
573 JAW DISORDER 19
574 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 19
575 MUSCULOSKELETAL DISCOMFORT 19
576 OCULAR HYPERAEMIA 19
577 PARKINSONIAN GAIT 19
578 PROCEDURAL PAIN 19
579 SEXUAL DYSFUNCTION 19
580 THROAT TIGHTNESS 19
581 ADVERSE REACTION 18
582 CATHETER SITE PAIN 18
583 CLOSTRIDIUM DIFFICILE INFECTION 18
584 COGWHEEL RIGIDITY 18
585 DEAFNESS 18
586 EAR INFECTION 18
587 INJECTION SITE NODULE 18
588 METABOLIC ENCEPHALOPATHY 18
589 MYDRIASIS 18
590 PARTIAL SEIZURES 18
591 PERIPHERAL COLDNESS 18
592 PRODUCT AVAILABILITY ISSUE 18
593 RESPIRATORY TRACT INFECTION 18
594 SECRETION DISCHARGE 18
595 SKIN CANCER 18
596 SPINAL OSTEOARTHRITIS 18
597 TUBULOINTERSTITIAL NEPHRITIS 18
598 UNINTENTIONAL MEDICAL DEVICE REMOVAL 18
599 WHEEZING 18
600 BACTERIAL INFECTION 17
601 CATHETER SITE ERYTHEMA 17
602 CATHETER SITE INFECTION 17
603 DEMENTIA WITH LEWY BODIES 17
604 DEVICE RELATED INFECTION 17
605 DISORGANISED SPEECH 17
606 DRUG EFFECT VARIABLE 17
607 GASTROINTESTINAL INFECTION 17
608 HAEMATOCHEZIA 17
609 HAEMORRHAGE INTRACRANIAL 17
610 HYPERKALAEMIA 17
611 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 17
612 INFUSION SITE SWELLING 17
613 LABORATORY TEST ABNORMAL 17
614 MEDICATION ERROR 17
615 ORAL DISCOMFORT 17
616 PNEUMOTHORAX 17
617 PRODUCT PRESCRIBING ERROR 17
618 RASH ERYTHEMATOUS 17
619 RESTING TREMOR 17
620 SARS-COV-2 TEST POSITIVE 17
621 SCOLIOSIS 17
622 SLEEP TERROR 17
623 SPINAL PAIN 17
624 STOMA SITE INFLAMMATION 17
625 SWOLLEN TONGUE 17
626 THERAPEUTIC PRODUCT EFFECT DELAYED 17
627 TIC 17
628 URINE ABNORMALITY 17
629 AFFECTIVE DISORDER 16
630 ASPARTATE AMINOTRANSFERASE INCREASED 16
631 BOWEL MOVEMENT IRREGULARITY 16
632 COVID-19 PNEUMONIA 16
633 DRUG LEVEL INCREASED 16
634 FACIAL PARALYSIS 16
635 GASTRIC DISORDER 16
636 HYPERAMMONAEMIC ENCEPHALOPATHY 16
637 INCREASED APPETITE 16
638 LACRIMATION INCREASED 16
639 LIGAMENT SPRAIN 16
640 LOSS OF CONTROL OF LEGS 16
641 NEUTROPHIL COUNT DECREASED 16
642 NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL 16
643 OCULAR DISCOMFORT 16
644 ORAL HERPES 16
645 OSTEOPOROSIS 16
646 POTENTIATING DRUG INTERACTION 16
647 PROSTATOMEGALY 16
648 PSYCHIATRIC SYMPTOM 16
649 RESPIRATORY DISORDER 16
650 RETCHING 16
651 SINUS DISORDER 16
652 SKIN BURNING SENSATION 16
653 SKIN LESION 16
654 SKIN MASS 16
655 TOXIC ENCEPHALOPATHY 16
656 URINE ANALYSIS ABNORMAL 16
657 AGEUSIA 15
658 BASAL CELL CARCINOMA 15
659 BENIGN PROSTATIC HYPERPLASIA 15
660 BONE PAIN 15
661 BRUXISM 15
662 CHOLECYSTECTOMY 15
663 COMPULSIONS 15
664 DEVICE POWER SOURCE ISSUE 15
665 DIVERTICULITIS 15
666 DRUG DEPENDENCE 15
667 DRUG EFFECT DELAYED 15
668 HAEMATURIA 15
669 HYPERAMMONAEMIA 15
670 HYPERLIPIDAEMIA 15
671 INFUSION SITE BRUISING 15
672 INFUSION SITE REACTION 15
673 INGUINAL HERNIA 15
674 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 15
675 LIVING IN RESIDENTIAL INSTITUTION 15
676 LYMPHADENOPATHY 15
677 MUTISM 15
678 NYSTAGMUS 15
679 PANCREATITIS 15
680 PATHOLOGICAL GAMBLING 15
681 POLYURIA 15
682 PSORIASIS 15
683 RECTAL HAEMORRHAGE 15
684 RHEUMATOID ARTHRITIS 15
685 SCRATCH 15
686 SLOW SPEECH 15
687 TERMINAL STATE 15
688 TRIGEMINAL NEURALGIA 15
689 TRISMUS 15
690 TROPONIN INCREASED 15
691 URINARY HESITATION 15
692 VITAMIN D DECREASED 15
693 WOUND INFECTION 15
694 ABDOMINAL PAIN LOWER 14
695 BACK DISORDER 14
696 BLEPHAROSPASM 14
697 BLOOD TEST ABNORMAL 14
698 CHOKING SENSATION 14
699 COMMUNICATION DISORDER 14
700 DEVICE COLOUR ISSUE 14
701 FIBROMYALGIA 14
702 FLUID INTAKE REDUCED 14
703 GASTROINTESTINAL TUBE INSERTION 14
704 GRAND MAL CONVULSION 14
705 GRIP STRENGTH DECREASED 14
706 GROIN PAIN 14
707 HAEMOPTYSIS 14
708 HEPATIC FUNCTION ABNORMAL 14
709 HYPOAESTHESIA ORAL 14
710 HYPORESPONSIVE TO STIMULI 14
711 IMPAIRED QUALITY OF LIFE 14
712 INFUSION SITE INFECTION 14
713 INJECTION SITE INDURATION 14
714 LACERATION 14
715 LOGORRHOEA 14
716 MUSCLE STRAIN 14
717 MUSCULOSKELETAL CHEST PAIN 14
718 PERSONALITY CHANGE 14
719 RELAPSING-REMITTING MULTIPLE SCLEROSIS 14
720 SCAR 14
721 STOMATITIS 14
722 STRIDOR 14
723 APHTHOUS ULCER 13
724 APPLICATION SITE ERYTHEMA 13
725 BIPOLAR DISORDER 13
726 BLOOD ALKALINE PHOSPHATASE INCREASED 13
727 BLOOD POTASSIUM INCREASED 13
728 BRADYPHRENIA 13
729 BRAIN INJURY 13
730 BREAST MASS 13
731 CARDIOVASCULAR DISORDER 13
732 CERVICAL VERTEBRAL FRACTURE 13
733 CIRCULATORY COLLAPSE 13
734 CLAVICLE FRACTURE 13
735 CLUMSINESS 13
736 CYST 13
737 DEVICE DEFECTIVE 13
738 DEVICE PLACEMENT ISSUE 13
739 DISINHIBITION 13
740 ECZEMA 13
741 ESCHERICHIA URINARY TRACT INFECTION 13
742 FACIAL PARESIS 13
743 FRACTURE 13
744 GALLBLADDER DISORDER 13
745 HAND FRACTURE 13
746 HEPATIC STEATOSIS 13
747 HIATUS HERNIA 13
748 HICCUPS 13
749 HYPOVOLAEMIA 13
750 IMMUNODEFICIENCY 13
751 IMPAIRED WORK ABILITY 13
752 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 13
753 INCORRECT PRODUCT ADMINISTRATION DURATION 13
754 INFUSION SITE HAEMORRHAGE 13
755 KNEE OPERATION 13
756 MAJOR DEPRESSION 13
757 MALIGNANT MELANOMA 13
758 MORPHOEA 13
759 PETIT MAL EPILEPSY 13
760 ROTATOR CUFF SYNDROME 13
761 SALIVA DISCOLOURATION 13
762 SCHIZOPHRENIA 13
763 SEASONAL ALLERGY 13
764 SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS 13
765 SINUS CONGESTION 13
766 SKIN HAEMORRHAGE 13
767 SOCIAL AVOIDANT BEHAVIOUR 13
768 SPINAL CORD HAEMATOMA 13
769 SPINAL STENOSIS 13
770 STATUS EPILEPTICUS 13
771 STOMA SITE EXTRAVASATION 13
772 STOMA SITE ODOUR 13
773 THERAPY CHANGE 13
774 TONGUE BITING 13
775 TOOTH DISORDER 13
776 TOOTH FRACTURE 13
777 VITREOUS FLOATERS 13
778 ABSCESS 12
779 ACNE 12
780 ANTICHOLINERGIC SYNDROME 12
781 ARTHROPOD BITE 12
782 BLOOD THYROID STIMULATING HORMONE DECREASED 12
783 BLOOD UREA INCREASED 12
784 CARDIAC FLUTTER 12
785 CATHETER SITE NODULE 12
786 COLITIS MICROSCOPIC 12
787 CORONARY ARTERY DISEASE 12
788 DELUSION OF PARASITOSIS 12
789 ELECTROCARDIOGRAM ABNORMAL 12
790 END STAGE RENAL DISEASE 12
791 ENDOCARDITIS 12
792 FEELING OF BODY TEMPERATURE CHANGE 12
793 FRACTURED COCCYX 12
794 GASTROENTERITIS 12
795 HEPATIC FAILURE 12
796 IMPAIRED DRIVING ABILITY 12
797 INTERNAL HAEMORRHAGE 12
798 LIVER FUNCTION TEST ABNORMAL 12
799 MASS 12
800 MUSCLE ATROPHY 12
801 NASAL DISCOMFORT 12
802 NEOPLASM MALIGNANT 12
803 PRODUCT DISTRIBUTION ISSUE 12
804 PRODUCT STORAGE ERROR 12
805 PROGRESSIVE MULTIPLE SCLEROSIS 12
806 PROSTATE CANCER 12
807 SEIZURE LIKE PHENOMENA 12
808 SKIN ULCER 12
809 SPINAL COMPRESSION FRACTURE 12
810 STARING 12
811 STEREOTYPY 12
812 STOMA SITE IRRITATION 12
813 TYPE 2 DIABETES MELLITUS 12
814 ULCER 12
815 VISUAL FIELD DEFECT 12
816 AFFECT LABILITY 11
817 ANHEDONIA 11
818 B-LYMPHOCYTE COUNT DECREASED 11
819 BACK INJURY 11
820 BLADDER CATHETERISATION 11
821 BLINDNESS UNILATERAL 11
822 BODY HEIGHT DECREASED 11
823 CATHETER SITE BRUISE 11
824 CATHETER SITE RELATED REACTION 11
825 DECREASED IMMUNE RESPONSIVENESS 11
826 DERMATITIS 11
827 DISABILITY 11
828 DIVERTICULUM 11
829 DRUG ADMINISTRATION ERROR 11
830 DUPLICATE THERAPY ERROR 11
831 EAR PAIN 11
832 FEELING DRUNK 11
833 FOETAL EXPOSURE DURING PREGNANCY 11
834 GASTROINTESTINAL MOTILITY DISORDER 11
835 GLYCOSYLATED HAEMOGLOBIN INCREASED 11
836 HAEMATEMESIS 11
837 HAEMORRHOIDS 11
838 HIP SURGERY 11
839 HYPERREFLEXIA 11
840 HYPERTONIC BLADDER 11
841 HYPOMANIA 11
842 IMPAIRED GASTRIC EMPTYING 11
843 INFUSION SITE CELLULITIS 11
844 INSURANCE ISSUE 11
845 INTENTIONAL SELF-INJURY 11
846 INTERVERTEBRAL DISC DEGENERATION 11
847 INTERVERTEBRAL DISC DISORDER 11
848 MACULAR OEDEMA 11
849 MALIGNANT NEOPLASM PROGRESSION 11
850 MICTURITION DISORDER 11
851 PAIN OF SKIN 11
852 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 11
853 POSTOPERATIVE WOUND INFECTION 11
854 PRODUCT ADHESION ISSUE 11
855 SEXUALLY INAPPROPRIATE BEHAVIOUR 11
856 SKIN INFECTION 11
857 SOMATIC DELUSION 11
858 SQUAMOUS CELL CARCINOMA 11
859 TEARFULNESS 11
860 THROMBOPHLEBITIS 11
861 THYROID DISORDER 11
862 TORTICOLLIS 11
863 WHITE MATTER LESION 11
864 ABORTION SPONTANEOUS 10
865 ANGINA PECTORIS 10
866 APHONIA 10
867 BLADDER CANCER 10
868 CARPAL TUNNEL SYNDROME 10
869 CATHETER SITE DISCHARGE 10
870 CATHETER SITE HAEMORRHAGE 10
871 CEREBRAL HYPOPERFUSION 10
872 CONJUNCTIVITIS 10
873 CORONARY ARTERY OCCLUSION 10
874 DEFAECATION URGENCY 10
875 DEMENTIA ALZHEIMER^S TYPE 10
876 DERMATITIS ALLERGIC 10
877 DEVICE EXPULSION 10
878 DEVICE LOOSENING 10
879 ENERGY INCREASED 10
880 EYE CONTUSION 10
881 FAECES DISCOLOURED 10
882 FAILURE TO THRIVE 10
883 FOOD INTOLERANCE 10
884 FOOD POISONING 10
885 GASTROSTOMY 10
886 GLOSSODYNIA 10
887 HYPERTHYROIDISM 10
888 HYPOTONIA 10
889 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 10
890 INCORRECT ROUTE OF DRUG ADMINISTRATION 10
891 INFUSION SITE INDURATION 10
892 INFUSION SITE IRRITATION 10
893 LIVER DISORDER 10
894 LIVER FUNCTION TEST INCREASED 10
895 LOCAL SWELLING 10
896 LUMBAR RADICULOPATHY 10
897 MALE SEXUAL DYSFUNCTION 10
898 MENINGITIS 10
899 MONOCYTE PERCENTAGE INCREASED 10
900 MUSCLE FATIGUE 10
901 NASAL DISCHARGE DISCOLOURATION 10
902 NO THERAPEUTIC RESPONSE 10
903 NODULE 10
904 OBESITY 10
905 OSTEONECROSIS 10
906 PAIN IN JAW 10
907 PARAESTHESIA ORAL 10
908 PHOTOSENSITIVITY REACTION 10
909 POST PROCEDURAL INFECTION 10
910 PRODUCT ADMINISTRATION INTERRUPTED 10
911 PRODUCT CLEANING INADEQUATE 10
912 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 10
913 PRODUCT PACKAGING DIFFICULT TO OPEN 10
914 PROSTATIC SPECIFIC ANTIGEN INCREASED 10
915 PRURITUS GENERALISED 10
916 PSYCHIATRIC DECOMPENSATION 10
917 PULMONARY FIBROSIS 10
918 RED CELL DISTRIBUTION WIDTH INCREASED 10
919 REFUSAL OF TREATMENT BY PATIENT 10
920 SEDATION COMPLICATION 10
921 SHOCK 10
922 SOFT TISSUE MASS 10
923 SUBCUTANEOUS ABSCESS 10
924 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 10
925 TASTE DISORDER 10
926 TENDON RUPTURE 10
927 TONGUE DISORDER 10
928 TOOTH ABSCESS 10
929 TOOTHACHE 10
930 URINARY TRACT DISORDER 10
931 URINE ODOUR ABNORMAL 10
932 VENTRICULAR TACHYCARDIA 10
933 VOLVULUS 10
934 ACCIDENT 9
935 ALTERED VISUAL DEPTH PERCEPTION 9
936 APPENDICECTOMY 9
937 BLOOD IMMUNOGLOBULIN G DECREASED 9
938 BRAIN NEOPLASM 9
939 CANDIDA INFECTION 9
940 CYANOSIS 9
941 DEMYELINATION 9
942 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 9
943 ENCEPHALITIS 9
944 EOSINOPHIL COUNT INCREASED 9
945 FACE INJURY 9
946 FACIAL PAIN 9
947 FAECES SOFT 9
948 FUNCTIONAL GASTROINTESTINAL DISORDER 9
949 GAIT SPASTIC 9
950 GOITRE 9
951 HOMICIDAL IDEATION 9
952 HYPERAESTHESIA 9
953 HYPERPYREXIA 9
954 HYSTERECTOMY 9
955 IMMUNE SYSTEM DISORDER 9
956 INJECTION SITE IRRITATION 9
957 JC POLYOMAVIRUS TEST POSITIVE 9
958 JEALOUS DELUSION 9
959 JOINT INSTABILITY 9
960 LARGE INTESTINE POLYP 9
961 LIVER INJURY 9
962 LYMPHOMA 9
963 NEPHROGENIC ANAEMIA 9
964 PALLIATIVE CARE 9
965 PANCYTOPENIA 9
966 PARKINSONIAN REST TREMOR 9
967 PNEUMOPERITONEUM 9
968 POISONING DELIBERATE 9
969 POLYP 9
970 PRODUCT DISPENSING ISSUE 9
971 PRODUCT USE COMPLAINT 9
972 PULMONARY CONGESTION 9
973 PYELONEPHRITIS 9
974 RED BLOOD CELL COUNT DECREASED 9
975 RESPIRATION ABNORMAL 9
976 RESPIRATORY SYNCYTIAL VIRUS INFECTION 9
977 SENSITIVE SKIN 9
978 SNORING 9
979 STOMA SITE INDURATION 9
980 STOMA SITE OEDEMA 9
981 SUDDEN DEATH 9
982 SYSTEMIC LUPUS ERYTHEMATOSUS 9
983 TOOTH EXTRACTION 9
984 UPPER-AIRWAY COUGH SYNDROME 9
985 URINE LEUKOCYTE ESTERASE POSITIVE 9
986 UTERINE LEIOMYOMA 9
987 VAGINAL HAEMORRHAGE 9
988 VENTRICULAR ARRHYTHMIA 9
989 VITAMIN B12 DECREASED 9
990 WEIGHT FLUCTUATION 9
991 WHITE BLOOD CELLS URINE POSITIVE 9
992 ABNORMAL LOSS OF WEIGHT 8
993 ABNORMAL SLEEP-RELATED EVENT 8
994 APPLICATION SITE PRURITUS 8
995 ATROPHY 8
996 ATTENTION DEFICIT/HYPERACTIVITY DISORDER 8
997 BASAL GANGLIA INFARCTION 8
998 BLOOD LACTIC ACID INCREASED 8
999 BLOOD PRESSURE SYSTOLIC INCREASED 8